Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-23

Clinical Trial Update: DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen [Phase 2]

View source ↗

Summary

This update reports the completed Phase 2 trial evaluating GAD-Alum (Diamyd) in combination with Vitamin D and Ibuprofen to preserve insulin secretion in indivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diamyd
  • Ibuprofen (IBUPROFEN)
  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Johnny Ludvigsson | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED